[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 2004

Disseminated Granuloma Annulare Resolved With the T-Cell Modulator Efalizumab

Arch Dermatol. 2004;140(10):1287-1288. doi:10.1001/archderm.140.10.1287

Granuloma annulare (GA) encompasses a benign group of granulomatous diseases that includes localized, disseminated (generalized), subcutaneous, and perforating types. Approximately 10% to 15% of patients have disseminated GA (DGA), which occurs primarily in adults and is characterized by multiple discrete or confluent papules with either an annular or a nonannular configuration.1

First Page Preview View Large
First page PDF preview
First page PDF preview